ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Inhibition of phosphodiesterase-4D in adults with fragile X syndrome: a randomized, placebo-controlled, phase 2 clinical trial
Nature Medicine
◽
10.1038/s41591-021-01321-w
◽
2021
◽
Author(s):
Elizabeth M. Berry-Kravis
◽
Mark D. Harnett
◽
Scott A. Reines
◽
Melody A. Reese
◽
Lauren E. Ethridge
◽
...
Keyword(s):
Clinical Trial
◽
Fragile X Syndrome
◽
Fragile X
◽
Phase 2
◽
Phase 2 Clinical Trial
◽
Phosphodiesterase 4D
Download Full-text
Related Documents
Cited By
References
Faculty Opinions recommendation of Inhibition of phosphodiesterase-4D in adults with fragile X syndrome: a randomized, placebo-controlled, phase 2 clinical trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.740023279.793585282
◽
2021
◽
Author(s):
R Frank Kooy
Keyword(s):
Clinical Trial
◽
Fragile X Syndrome
◽
Fragile X
◽
Phase 2
◽
Phase 2 Clinical Trial
◽
Phosphodiesterase 4D
Download Full-text
Comparison of a Novel Tazarotene 0.045% Lotion to Tazarotene 0.1% Cream: Patient-Reported Outcomes from a Phase 2 Clinical Trial
SKIN The Journal of Cutaneous Medicine
◽
10.25251/skin.3.supp.9
◽
2019
◽
Vol 3
◽
pp. S9
Author(s):
Zoe Draelos
◽
Fran Cook-Bolden
◽
Lawrence Green
◽
Eric Guenin
◽
Gina Martin
◽
...
Keyword(s):
Clinical Trial
◽
Patient Reported Outcomes
◽
Phase 2
◽
Patient Reported
◽
Phase 2 Clinical Trial
Abstract not available.
Download Full-text
Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas
Case Medical Research
◽
10.31525/ct1-nct04283669
◽
2020
◽
Author(s):
Keyword(s):
Clinical Trial
◽
Neurofibromatosis Type
◽
Neurofibromatosis Type 2
◽
Vestibular Schwannomas
◽
Phase 2
◽
Phase 2 Clinical Trial
Download Full-text
Faculty Opinions recommendation of Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.1047842.497861
◽
2006
◽
Author(s):
David Sullivan
Keyword(s):
Clinical Trial
◽
Plasmodium Falciparum
◽
Combination Therapy
◽
Falciparum Malaria
◽
Plasmodium Falciparum Malaria
◽
Phase 2
◽
Phase 2 Clinical Trial
◽
Uncomplicated Plasmodium Falciparum Malaria
◽
Randomized Phase 2
Download Full-text
Faculty Opinions recommendation of Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas: A Phase 2 Clinical Trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.727784209.793552909
◽
2018
◽
Author(s):
Warren A Chow
Keyword(s):
Clinical Trial
◽
Macrophage Infiltration
◽
Phase 2
◽
Pathway Activation
◽
Phase 2 Clinical Trial
Download Full-text
Phase 2 Clinical Trial of Intraoral Grafting of Human Tissue-Engineered Oral Mucosa
10.21236/ada591622
◽
2013
◽
Author(s):
Stephen E. Feinberg
Keyword(s):
Clinical Trial
◽
Oral Mucosa
◽
Human Tissue
◽
Phase 2
◽
Phase 2 Clinical Trial
Download Full-text
A Descriptive Cost‐Analysis of MYX.1/MCRN003, a Phase 2 Clinical Trial Evaluating High‐dose Weekly Carfilzomib, Cyclophosphamide, and Dexamethasone in Relapsed and Refractory Multiple Myeloma
European Journal Of Haematology
◽
10.1111/ejh.13671
◽
2021
◽
Author(s):
Bethany E. Monteith
◽
Christopher P. Venner
◽
Matthew C. Cheung
◽
Joe Pater
◽
Lois Shepherd
◽
...
Keyword(s):
Clinical Trial
◽
Multiple Myeloma
◽
Cost Analysis
◽
High Dose
◽
Phase 2
◽
Refractory Multiple Myeloma
◽
Phase 2 Clinical Trial
Download Full-text
Number Needed to Treat and Number Needed to Harm analysis of the zuranolone phase 2 clinical trial results in major depressive disorder
Journal of Affective Disorders
◽
10.1016/j.jad.2021.02.027
◽
2021
◽
Vol 285
◽
pp. 112-119
Author(s):
Alix Arnaud
◽
Ellison Suthoff
◽
Katie Stenson
◽
Brian Werneburg
◽
Paul Hodgkins
◽
...
Keyword(s):
Clinical Trial
◽
Major Depressive Disorder
◽
Depressive Disorder
◽
Number Needed To Treat
◽
Phase 2
◽
Major Depressive
◽
Phase 2 Clinical Trial
◽
Clinical Trial Results
◽
Number Needed To Harm
Download Full-text
41. Repeated Autologous Infusions of Cells Modified with VSV-G-Pseudotyped Lentiviral Vector VRX496 Can Induce Anti-VSV-G Humoral Response in Humans without Clinical Consequence or Effect on Modified Cells Persistence: Findings from Lexgenleucel-T Phase 2 Clinical Trial
Molecular Therapy
◽
10.1016/s1525-0016(16)37482-2
◽
2010
◽
Vol 18
◽
pp. S17-S18
Keyword(s):
Clinical Trial
◽
Lentiviral Vector
◽
Humoral Response
◽
Clinical Consequence
◽
Phase 2
◽
Phase 2 Clinical Trial
◽
T Phase
Download Full-text
Combined Preoperative Hypofractionated Radiotherapy With Doxorubicin-Ifosfamide Chemotherapy in Marginally Resectable Soft Tissue Sarcomas: Results of a Phase 2 Clinical Trial
International Journal of Radiation Oncology*Biology*Physics
◽
10.1016/j.ijrobp.2021.02.019
◽
2021
◽
Author(s):
Mateusz J. Spałek
◽
Hanna Koseła-Paterczyk
◽
Aneta Borkowska
◽
Michał Wągrodzki
◽
Anna Szumera-Ciećkiewicz
◽
...
Keyword(s):
Clinical Trial
◽
Soft Tissue
◽
Soft Tissue Sarcomas
◽
Hypofractionated Radiotherapy
◽
Phase 2
◽
Phase 2 Clinical Trial
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close